Lonza completed a laboratory expansion project at its API manufacturing facility in Nansha, China. The project, which grew the footprint of the lab by 250 square meters, included the addition of new ...
The Immunosuppressants API market offers significant growth potential driven by increasing prevalence of autoimmune diseases ...
“Our customers, in partnership with federal and state agencies, are reshoring drug manufacturing in the U.S., the world’s largest pharmaceutical market. Local API production is vital for supply chain ...
North America: Largest market, powered by high drug consumption, strong regulatory frameworks, and advanced biotech manufacturing infrastructure. Asia Pacific: Fastest-growing, led by India's contract ...
Cequence Security, the provider of unified API protection, is unveiling the latest testing capabilities—API Security Testing—for its unified API protection platform. Focused on pre-production ...
Wuxi STA, a subsidiary of WuXi AppTec, continued its manufacturing expansion march with the opening of another high-potency active pharmaceutical ingredient (HPAPI) production facility in China. The ...
SAN FRANCISCO--(BUSINESS WIRE)--Postman, the world’s leading API collaboration platform, today released the findings of its sixth annual 2024 State of the API Report, the industry’s most comprehensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback